Original Source(s)
Related Content
FDA Approves New First-Line TNBC Regimen
Phase 3 results showed longer progression-free survival with pembrolizumab plus sacituzumab govitecan-hziy than with pembrolizumab plus chemotherapy in previously untreated PD-L1-positive advanced triple-negative breast cancer.
June 26, 2026
-
3 min
Side Effects: Bro Science, Actually
Creatine's ATP-buffering trick isn't just for biceps. In mice, it juices up dendritic cells' energy supply, sharpening T-cell priming and shrinking tumors on daily injections. Human DCs got the memo too, at least in a dish. Early days, but a fun plot twist for gym-bag chemistry.
by Kerri Miller
July 8, 2026
-
6 min
Diabetes Risk Scores: Beyond Glucose
Multi-ancestry polygenic models identify high-risk patients traditional screening may miss.
May 13, 2026
-
5 min